Z24-18351-65625
3 vaccinations
2 coded responses
34 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
- 2020-12-16
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
-
2020-12-30
Survey response — day 14, dose 1MedDRA: Injection site pruritus, Injection site rash, Injection site swelling — Feeling: GoodFree text: Approximately 1 week after injection, had rash, itching, and mild swelling at injection site. No other symptoms, no pain. Resolved within 48 hours without any medications or other interventions.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-06
Dose 2 — Pfizer-BioNTech
- 2021-01-06
-
2021-01-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-07
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-08
- 2021-01-09
- 2021-01-13
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-04-07
- 2021-07-07
-
2021-09-25
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Survey response — days 1–6 daily, dose 3MedDRA: Chills, Fatigue, Headache, Myalgia, Pyrexia, Self-medication — Feeling: GoodFree text: Had fever, chills, myalgias, fatigue, headache from 12 hours post-vaccine until ~36 hours post vaccine. Treated at home with tylenol, supportive care; no presentation to medical care needed. Symptoms now completely resolved.MedDRA releases: 2024-11 · check-in free text available
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-12-25
- 2022-03-26
- 2022-09-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-07 | priority 2/3 |
Free text
Release 1 — day 14, dose 1
Symptoms: Approximately 1 week after injection, had rash, itching, and mild swelling at injection site. No other symptoms, no pain. Resolved within 48 hours without any medications or other interventions.
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Had fever, chills, myalgias, fatigue, headache from 12 hours post-vaccine until ~36 hours post vaccine. Treated at home with tylenol, supportive care; no presentation to medical care needed. Symptoms now completely resolved.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Pruritus | ○ | ○ | ○ |
| SD | Rash | ○ | ○ | ○ |
| SRO | Chills | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Myalgia | · | · | ✓ |
| SRO | Pyrexia | · | · | ✓ |
| SRO | Self-medication | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release